TY - JOUR
T1 - Inflammatory myofibroblastic tumors
AU - Kovach, Stephen J.
AU - Fischer, Anne C.
AU - Katzman, Philip J.
AU - Salloum, Rabih M.
AU - Ettinghausen, Stephen E.
AU - Madeb, Ralph
AU - Koniaris, Leonidas G.
PY - 2006/10/1
Y1 - 2006/10/1
N2 - Introduction: Inflammatory myofibroblastic tumors (IMT) while uncommon may arise within numerous organs. Historically, the literature regarding IMT has been confined to small one organ case series, with few reviews encompassing multiple anatomic sites, and little data regarding adjuvant treatment. Methods: A review of patients with IMT treated at two large academic medical centers over a 15-year period was undertaken. Patient demographics, pathologic diagnoses, and pertinent clinical data were obtained. Results: Forty-four cases of pathologically confirmed IMT were identified. Tumor locations included multiple anatomic sites. Therapies included complete resection, incomplete resection, observation, or chemotherapy, and/or radiation. Five patients underwent adjuvant chemotherapy and/or radiation therapy following surgery (14%) for local aggressiveness of the tumor, invasion, positive margins, or location of tumor that was not amenable to surgical resection. A second, concomitant, histologically distinct, neoplasm was identified in five cases. Of the patients who underwent treatment three local recurrences were noted (8%) and occurred in patients with partial resection without adjuvant chemo- or radiotherapy. Conclusions: Inflammatory myofibroblastic tumors may be a locally aggressive and destructive neoplasm. Tumor recurrence is unusual following complete surgical resection or organ-preserving combined modality therapy.
AB - Introduction: Inflammatory myofibroblastic tumors (IMT) while uncommon may arise within numerous organs. Historically, the literature regarding IMT has been confined to small one organ case series, with few reviews encompassing multiple anatomic sites, and little data regarding adjuvant treatment. Methods: A review of patients with IMT treated at two large academic medical centers over a 15-year period was undertaken. Patient demographics, pathologic diagnoses, and pertinent clinical data were obtained. Results: Forty-four cases of pathologically confirmed IMT were identified. Tumor locations included multiple anatomic sites. Therapies included complete resection, incomplete resection, observation, or chemotherapy, and/or radiation. Five patients underwent adjuvant chemotherapy and/or radiation therapy following surgery (14%) for local aggressiveness of the tumor, invasion, positive margins, or location of tumor that was not amenable to surgical resection. A second, concomitant, histologically distinct, neoplasm was identified in five cases. Of the patients who underwent treatment three local recurrences were noted (8%) and occurred in patients with partial resection without adjuvant chemo- or radiotherapy. Conclusions: Inflammatory myofibroblastic tumors may be a locally aggressive and destructive neoplasm. Tumor recurrence is unusual following complete surgical resection or organ-preserving combined modality therapy.
KW - Fibromyxoid
KW - Inflammatory myofibroblastic tumor
KW - Inflammatory pseudotumor
KW - Pseudosarcomatous myofibroblastic
KW - Spindle cell granuloma
UR - http://www.scopus.com/inward/record.url?scp=33749075544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33749075544&partnerID=8YFLogxK
U2 - 10.1002/jso.20516
DO - 10.1002/jso.20516
M3 - Article
C2 - 16967468
AN - SCOPUS:33749075544
SN - 0022-4790
VL - 94
SP - 385
EP - 391
JO - Journal of Surgical Oncology
JF - Journal of Surgical Oncology
IS - 5
ER -